{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P28906",
      "entity_text" : "CD34",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0279" ],
      "Cellular_component" : [ "uniprot:SL-0027" ],
      "CellType" : [ "cl:CL:0002092" ],
      "Species" : [ "taxonomy:10090" ]
    }
  },
  "verbose_text" : "The first, the expression of IL-5Ralpha on CD34+ progenitor cells, was examined since there is an increase in the proportion of bone marrow CD34 + progenitor cells expressing IL-5Ralpha 24 hours after allergen challenge in asthmatic subjects [XREF_BIBR], and pretreatment with BUD in vivo partially reduces baseline levels of CD34 + IL-5Ralpha + bone marrow cells, but does not abrogate the allergen induced upregulation [XREF_BIBR].",
  "reading_complete" : "2020-08-03T11:49:27Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T11:44:49Z",
  "trigger" : "levels",
  "evidence" : [ "levels of CD34" ],
  "pmc_id" : "2606647",
  "score" : 0
}